News | April 12, 2026
C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Subscribe To Our Newsletter & Stay Updated
